All News

Addressing gaps in testing and education within precision oncology can assist in improving access to patients of color and other underserved populations.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Spinal cord stimulation was found to decrease pain and reduce motor symptoms of Parkinson disease as both a singular therapy and as a salvage therapy after deep brain stimulation therapies proved ineffective.

The study of over 8000 patients with myeloproliferative neoplasms (MPNs) also found that these patients were 40% more likely to have a prior diagnosis of inflammatory bowel disease (IBD).

President Donald Trump is showing symptoms after testing positive for the virus that causes coronavirus disease 2019. He received an experimental antibody cocktail and was taken to Walter Reed Medical Center.

The FDA action follows presentation of results in August during the European Society of Cardiology 2020 Virtual Congress.

The results of a recent study out of South Korea show that diet management education appeared more important to health care providers than it did their patients, while both expressed the significance of medication knowledge.

A patient with chronic lymphocytic leukemia (CLL) was continued on ibrutinib even after developing severe coronavirus disease 2019 (COVID-19). He successfully overcame the infection.

In working directly with employers on their purchasing strategies amid the COVID-19 pandemic, notable concerns include independent primary care, consolidation, and quality of care.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Democrats passed a $2.2 trillion pandemic aid bill; Ohio reports the deadliest overdose month in over a decade; the American Medical Association (AMA) asks for an abortion rule to be overturned.

This week, the top managed care news included progress made in diabetes technology coverage and access among Medicare beneficiaries; an inside look into how colleges and universities addressed the COVID-19 pandemic; a recap of the Patient-Centered Oncology Care® 2020 virtual meeting.

The researchers found that just 13% of participating providers adhered to the recommended low dose (40 mg) of oral prednisone for patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).

Results from a study on Canadian women who did and did not participate in a population-based breast cancer screening program show that interval breast cancers are more aggressive and deadlier than screening-detected cancers.

Andre Goy, MD, of John Theurer Cancer Center, discussed what we’ve learned from existing chimeric antigen receptor T (CAR T)-cell therapies in managing cytokine responses.

In patients with idiopathic epiretinal membrane (ERM), membrane contraction contributed to increased choroidal thickness, according to study results published in PLoS One.

Former e-cigarette users were found to be more likely to report sleep deprivation compared with never users, according to study findings.

A House panel found pharmaceutical companies exponentially increased drug prices to boost profits; CDC data show an increase in alcohol-related deaths, especially among women; 4 million more Americans enroll in Medicaid.

Patients testing positive for severe acute respiratory syndrome (SARS-CoV-2), the virus that causes coronavirus disease 2019, are presenting more often with signs of heart failure with preserved ejection fraction (HFpEF).

Efficacy and safety of atezolizumab as first-line therapy for metastatic non–small cell lung cancer (NSCLC) with high levels of PD-L1 expression is not known, the authors said.

The majority of patients with asthma have type 2 inflammation, and the introduction of dupilumab has changed the treatment space for these patients, said Neal Jain, MD, FAAP, FAAAAI.

Study results presented during the virtual European Society for Medical Oncology meeting demonstrated the superiority of cemiplimab (Libtayo) plus ipilimumab vs cemiplimab monotherapy for non–small cell lung cancer.

Amid disruption precipitated by the coronavirus disease 2019 (COVID-19) pandemic, a survey by the National Alliance of Healthcare Purchaser Coalitions shows employers are maintaining or accelerating their health benefit strategies for 2021 and 2022.

A new review article said there are hurdles to bringing minimal residual disease (MRD) into the clinic as a decision-making tool, but the day is likely not far away.

Research into children and adolescents with nonremission acute lymphoblastic leukemia (ALL) has been sparse, but a new analysis suggests that allogeneic hematopoietic stem cell transplantation is a good fit for some patients.

The aftereffects of coronavirus disease 2019 (COVID-19) are being studied in recovering patients; Regeneron’s COVID-19 antibody cocktail may induce quicker recovery; Timothy Ray Brown, the first patient reportedly cured of HIV, has died.

There were a myriad of factors considered when deciding how to reopen higher education institutions amid the COVID-19 pandemic, particularly in prioritizing the safety of students, faculty, and community members, as well as the quality of education delivered.

Despite decades of experimentation, there have not been large increases in health care quality in the United States. What will move the needle?